Both monocytes and neutrophils displayed strongly elevated expression of variant 1 and CD274-L2A following IFN-β treatment of MS patients, with monocytes expressing the two variants at nearly equal levels (Figure 3D). Here, IFNB1 is linked to myeloid sarcoma.